| RS2092912932 |
NAGLU
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis |
| RS2092914076 |
NAGLU
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS2092920511 |
NAGLU
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS2092925480 |
NAGLU
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis |
| RS2092925958 |
NAGLU
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis |
| RS2092926507 |
NAGLU
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS2092926516 |
NAGLU
|
Health Risk |
Likely pathogenic |
— |
| RS2092926604 |
UNC80
|
Health Risk |
Likely pathogenic |
— |
| RS2092928057 |
NAGLU
|
Health Risk |
Pathogenic |
— |
| RS2092928624 |
NAGLU
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS2092930339 |
NAGLU
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis |
| RS2092930484 |
NAGLU
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis |
| RS2092930640 |
IGH;IGHM
|
Health Risk |
Likely pathogenic |
Autosomal recessive agammaglobulinemia 1, Autosomal recessive agammaglobulinemia 1 |
| RS2092933941 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2092939625 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2092939869 |
PKD1
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS2092939979 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, Polycystic kidney disease |
| RS2092940490 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS2092941002 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS2092941027 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2092941062 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2092941253 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2092941432 |
PKD1
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS2092986219 |
DEPDC5
|
Health Risk |
Pathogenic |
Autosomal dominant nocturnal frontal lobe epilepsy, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS2092992348 |
COASY
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 6, Neurodegeneration with brain iron accumulation 6 |
| RS2092996974 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2093000714 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2093001133 |
COASY
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 6, Neurodegeneration with brain iron accumulation 6 |
| RS2093032018 |
UNC80
|
Health Risk |
Pathogenic |
— |
| RS2093045125 |
PSMC3IP
|
Health Risk |
Pathogenic |
Ovarian dysgenesis 3, Ovarian dysgenesis 3 |
| RS2093122605 |
DEPDC5
|
Health Risk |
Pathogenic |
— |
| RS2093126233 |
TRAF7
|
Health Risk |
Likely pathogenic |
— |
| RS2093132159 |
TRAF7
|
Health Risk |
Pathogenic/Likely pathogenic |
TRAF7-related disorder, Cardiac |
| RS2093135960 |
TRAF7
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiac, facial |
| RS2093148818 |
TTN
|
Health Risk |
Likely pathogenic |
Myopathy, myofibrillar |
| RS2093158866 |
TTN
|
Health Risk |
Pathogenic |
Centronuclear myopathy, Centronuclear myopathy |
| RS2093189899 |
DYSF
|
Health Risk |
Pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy |
| RS2093194038 |
CLN6
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2093199030 |
CLN6
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2093204342 |
CLN6
|
Health Risk |
Likely pathogenic |
Adult neuronal ceroid lipofuscinosis, Ceroid lipofuscinosis |
| RS2093204407 |
CLN6
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2093205953 |
CLN6
|
Health Risk |
Likely pathogenic |
Adult neuronal ceroid lipofuscinosis, Ceroid lipofuscinosis |
| RS2093207581 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2093214695 |
CLN6
|
Health Risk |
Likely pathogenic |
Adult neuronal ceroid lipofuscinosis, Ceroid lipofuscinosis |
| RS2093220811 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Miyoshi muscular dystrophy 1 |
| RS2093221854 |
KMT2C
|
Health Risk |
Pathogenic |
Rare genetic intellectual disability, Kleefstra syndrome 2 |
| RS2093222376 |
DYSF
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Miyoshi muscular dystrophy 1 |
| RS2093229974 |
QRICH1
|
Health Risk |
Likely pathogenic |
Ververi-Brady syndrome, Ververi-Brady syndrome |
| RS2093231242 |
KMT2C
|
Health Risk |
Pathogenic |
Neurodevelopmental abnormality, Autism spectrum disorder |
| RS2093235396 |
KMT2C
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 2 |
| RS2093252843 |
QRICH1
|
Health Risk |
Pathogenic |
Mild intellectual disability, Ververi-Brady syndrome |
| RS2093252866 |
QRICH1
|
Health Risk |
Likely pathogenic |
Ververi-Brady syndrome, Ververi-Brady syndrome |
| RS2093262385 |
CLN6
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2093262507 |
CLN6
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2093262869 |
CLN6
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis, Ceroid lipofuscinosis |
| RS2093280280 |
MYO18B
|
Health Risk |
Likely pathogenic |
— |
| RS2093332969 |
RIMS2
|
Health Risk |
Pathogenic |
Cone-rod synaptic disorder syndrome, congenital nonprogressive |
| RS2093334853 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2093339890 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy, Nemaline myopathy |
| RS2093352256 |
STIM1
|
Health Risk |
Likely pathogenic |
Myopathy, tubular aggregate |
| RS2093406628 |
QRICH1
|
Health Risk |
Pathogenic |
— |
| RS2093408453 |
QRICH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ververi-Brady syndrome, Ververi-Brady syndrome |
| RS2093408575 |
QRICH1
|
Health Risk |
Pathogenic |
Intellectual disability, Ververi-Brady syndrome |
| RS2093410241 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2093411936 |
QRICH1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2093412592 |
QRICH1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2093414203 |
KMT2C
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2093435062 |
KMT2C
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 2, Kleefstra syndrome 2 |
| RS2093437797 |
KMT2C
|
Health Risk |
Pathogenic |
— |
| RS2093442517 |
EMC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Cerebellar atrophy |
| RS2093445172 |
UNC80
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypotonia, infantile |
| RS2093462674 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2093464314 |
DYSF
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Miyoshi muscular dystrophy 1 |
| RS2093486364 |
DEPDC5
|
Health Risk |
Pathogenic/Likely pathogenic |
Epilepsy, Epilepsy |
| RS2093489078 |
KMT2C
|
Health Risk |
Likely pathogenic |
Kleefstra syndrome 2, Kleefstra syndrome 2 |
| RS2093489538 |
DEPDC5
|
Health Risk |
Pathogenic |
— |
| RS2093531358 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Miyoshi muscular dystrophy 1 |
| RS2093531900 |
DYSF
|
Health Risk |
Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2093533157 |
EMC1
|
Health Risk |
Pathogenic |
— |
| RS2093571190 |
FCHO1
|
Health Risk |
Pathogenic |
Severe congenital neutropenia, Immunodeficiency 76 |
| RS2093575654 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2093588528 |
EMC1
|
Health Risk |
Likely pathogenic |
— |
| RS2093597511 |
EMC1
|
Health Risk |
Pathogenic |
— |
| RS2093611226 |
EMC1
|
Health Risk |
Likely pathogenic |
— |
| RS2093614668 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2093617332 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2093618217 |
EMC1
|
Health Risk |
Pathogenic |
— |
| RS2093621567 |
RBFOX1
|
Health Risk |
Pathogenic |
Colorectal cancer, Colorectal cancer |
| RS2093649055 |
ABCA3
|
Health Risk |
Likely pathogenic |
Interstitial lung disease 2, Interstitial lung disease 2 |
| RS2093650935 |
ABCA3
|
Health Risk |
Pathogenic |
Interstitial lung disease due to ABCA3 deficiency, Hereditary pulmonary alveolar proteinosis |
| RS2093652593 |
DEPDC5
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2093654880 |
ABCA3
|
Health Risk |
Pathogenic |
Interstitial lung disease due to ABCA3 deficiency, Hereditary pulmonary alveolar proteinosis |
| RS2093657764 |
ABCA3
|
Health Risk |
Pathogenic |
Hereditary pulmonary alveolar proteinosis, Hereditary pulmonary alveolar proteinosis |
| RS2093657780 |
ABCA3
|
Health Risk |
Pathogenic |
— |
| RS2093657978 |
ABCA3
|
Health Risk |
Likely pathogenic |
Interstitial lung disease due to ABCA3 deficiency, Interstitial lung disease due to ABCA3 deficiency |
| RS2093658427 |
KMT2C
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2093658825 |
EMC1
|
Health Risk |
Likely pathogenic |
— |
| RS2093663770 |
ABCA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Interstitial lung disease due to ABCA3 deficiency, Hereditary pulmonary alveolar proteinosis |
| RS2093669726 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2093682532 |
ABCA3
|
Health Risk |
Pathogenic |
Interstitial lung disease due to ABCA3 deficiency, Interstitial lung disease due to ABCA3 deficiency |